CombiMatrix

CombiMatrix is a clinical diagnostic laboratory specializing in cytogenomic testing for prenatal diagnosis, miscarriage analysis, pediatric developmental disorders and preimplantation genetic screening (PGS). As a full-scale cytogenetic and cytogenomic laboratory, CombiMatrix offers chromosomal microarray analysis, standard and customized FISH, and high resolution karyotyping to help clinicians better care for their patients. 
Company Growth (employees)
Type
Public
HQ
Irvine, US
Founded
1995
Size (employees)
55 (est)-15%
CombiMatrix was founded in 1995 and is headquartered in Irvine, US

Key People at CombiMatrix

Scott Burell

Scott Burell

CFO
Judd Jessup

Judd Jessup

Chairman
Scott Gottlieb

Scott Gottlieb

Member of the Board of Directors
Karine Hovanes

Karine Hovanes

VP of Scientific Advancement & Laboratory Director
Robert E. Hoffman

Robert E. Hoffman

Member of the Board of Directors

CombiMatrix Office Locations

CombiMatrix has an office in Irvine
Irvine, US (HQ)
100 300 Goddard
Irvine, US
150 310 Goddard

CombiMatrix Data and Metrics

CombiMatrix Financial Metrics

CombiMatrix's revenue was reported to be $12.9 m in FY, 2016 which is a 28% increase from the previous period.
USD

Revenue (FY, 2016)

12.9 m

Revenue growth (FY, 2015 - FY, 2016), %

28%

Gross profit (FY, 2016)

7.1 m

Gross profit margin (FY, 2016), %

55%

Net income (FY, 2016)

(4.1 m)

EBIT (FY, 2016)

(4.1 m)

Market capitalization (19-Jul-2017)

16.4 m

Closing share price (19-Jul-2017)

5.7

Cash (31-Dec-2016)

2.7 m
CombiMatrix's current market capitalization is $16.4 m.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

6.4 m8 m10.1 m12.9 m

Revenue growth, %

26%25%28%

Cost of goods sold

3.5 m4.4 m5.4 m5.8 m

Gross profit

2.8 m3.6 m4.6 m7.1 m

Gross profit Margin, %

45%45%46%55%

Sales and marketing expense

4.6 m

R&D expense

493 k

General and administrative expense

6 m

Operating expense total

12.8 m16.8 m16.6 m17 m

EBIT

(6.4 m)(8.8 m)(6.5 m)(4.1 m)

EBIT margin, %

(100%)(109%)(65%)(32%)

Interest expense

356 k84 k79 k69 k

Interest income

5 k23 k16 k22 k

Net Income

(3.9 m)(8.7 m)(6.6 m)(4.1 m)
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

12.3 m1 m653 k2.7 m

Current Assets

16 m7.9 m7.2 m7.9 m

PP&E

581 k584 k691 k597 k

Total Assets

16.8 m8.6 m7.9 m8.5 m

Accounts Payable

36.8 m

Current Liabilities

2.1 m1.3 m1.8 m1.8 m

Total Liabilities

2 m

Additional Paid-in Capital

95.1 m96.3 m102.7 m109.1 m

Retained Earnings

(80.4 m)(96.8 m)(102.6 m)

Total Equity

14.7 m7.1 m5.9 m6.5 m

Financial Leverage

1.1 x1.2 x1.4 x1.3 x
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(3.9 m)(8.7 m)(6.6 m)(4.1 m)

Depreciation and Amortization

698 k317 k297 k258 k

Accounts Receivable

(723 k)(662 k)(823 k)(1.1 m)

Cash From Operating Activities

(5.6 m)(8.6 m)(5.7 m)(3.9 m)

Purchases of PP&E

(304 k)(72 k)(157 k)

Cash From Investing Activities

(2.1 m)(2.8 m)908 k2.1 m

Long-term Borrowings

(184 k)(188 k)

Cash From Financing Activities

17.6 m132 k4.5 m3.9 m

Interest Paid

40 k
Y, 2016

Financial Leverage

1.3 x

CombiMatrix Market Value History

CombiMatrix Online and Social Media Presence

CombiMatrix Company Life and Culture

You may also be interested in